SIAS
EBS icon

Shine Investment Advisory Services’s Emergent Biosolutions EBS Stock Holding History

Shine Investment Advisory Services’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$0 Hold
4
– – ﹤0.01% 724
2020
Q2 		$0 Hold
4
– – ﹤0.01% 735
2020
Q1 		$0 Hold
4
– – ﹤0.01% 728
2019
Q4 		$0 Buy
+4
New +$217 ﹤0.01% 736

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Shine Investment Advisory Services's EBS Position: Q3 2020 in Review

Shine Investment Advisory Services held its Emergent Biosolutions (EBS) position steady in Q3 2020 at 4 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #724.

Shine Investment Advisory Services first reported a position in EBS in Q4 2019 and has held it in 4 quarters since. 358 funds tracked by Wall St. Rank hold EBS as of Q3 2020.

  • Shine Investment Advisory Services held 4 shares of Emergent Biosolutions worth $0 as of Q3 2020.
  • Shine Investment Advisory Services left its Emergent Biosolutions share count unchanged in Q3 2020.
  • Emergent Biosolutions made up ﹤0.01% of Shine Investment Advisory Services's portfolio in Q3 2020, its #724 holding.
  • Shine Investment Advisory Services first reported a position in Emergent Biosolutions in Q4 2019 and has held it in 4 quarters since.
  • 358 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2020.

Based on Shine Investment Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.